Exosomes derived from these hypoxic tumor cells carry immunosuppressive molecules, especially TGF-β1 and miR-23a, which impair the cytotoxicity of NK cells and trigger bevacizumab resistance in lung cancer [138]. This evidence concerns the gene TGFB1 and neoplasm.